Concepedia

Publication | Closed Access

Minimal residual disease‐based augmented therapy in childhood acute lymphoblastic leukemia: A report from the Japanese Childhood Cancer and Leukemia Study Group

DOI

40

Citations

25

References

2010

Year

Kazutaka Yamaji, Tomomi Okamoto, Shohei Yokota, Arata Watanabe, Yasuo Horikoshi, Keiko Asami, Atsushi Kikuta, Nobuyuki Hyakuna, Yutaka Saikawa, Junichi Ueyama,
Pediatric Blood & Cancer

Abstract

These results suggest that augmented therapy for MRD-positive patients at TP2 contributed to better outcomes of the ALL2000 study.

References

YearCitations

Page 1